Skip to main content
. 2018 Aug 7;3(2):177–188. doi: 10.1007/s41669-018-0089-9

Fig. 3.

Fig. 3

Monthly healthcare costs per patient evaluated during the four quarters prior to PP3M transition. P values were obtained using a non-parametric bootstrap procedure with 500 replicates. *p value < 0.05. PP3M once-every-3-months paliperidone palmitate, USD US dollars